Management of Chronic Myelocytic Leukemia in Pregnancy by Cell Pheresis
- 2 January 1978
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 18 (1) , 120-124
- https://doi.org/10.1046/j.1537-2995.1978.18178118555.x
Abstract
Cell pheresis was employed in the initial management of a pregnant patient with chronic myelocytic leukemia (CML). Reduction in circulating leukocyte and platelet counts was evident after 2 wk of therapy. This technique is an effective mode of management of the pregnant patient with CML and may play an important therapeutic role in the treatment of other myeloproliferative diseases characterized by dangerously high levels of circulating platelets or myeloblasts.This publication has 21 references indexed in Scilit:
- Successful Control of Life‐Threatening Thrombocytosis with a Blood ProcessorTransfusion, 1975
- Leukapheresis of a Five‐Year‐Old Girl with Chronic Granulocytic LeukemiaTransfusion, 1975
- Chronic granulocytic leukaemia in pregnancyThe British Journal of Radiology, 1975
- Continuous Flow Centrifuge Leucapheresis in the Management of Chronic Myelogenous LeukaemiaBritish Journal of Haematology, 1975
- Busulfan treatment of leukemia during pregnancy. Case report and review of the literatureJAMA, 1967
- Busulfan in PregnancyJAMA, 1965
- Busulfan in PregnancyPublished by American Medical Association (AMA) ,1962
- CONCEPTION AND PREGNANCY IN A PATIENT WITH CHRONIC MYELOCYTIC LEUKEMIA UNDER CONTINUOUS COLCEMIDE THERAPYAnnals of Internal Medicine, 1959
- Use of Busulfan in Myelogenous Leukemia during PregnancyNew England Journal of Medicine, 1958
- LEUKEMIA AND PREGNANCYJAMA, 1956